- Home
- TRVI vs AIP Comparison
TRVI vs AIP Comparison
Compare TRVI & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AIP
- Stock Information
- Founded
- TRVI 2011
- AIP 2003
- Country
- TRVI United States
- AIP United States
- Employees
- TRVI N/A
- AIP N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- TRVI Health Care
- AIP Technology
- Exchange
- TRVI Nasdaq
- AIP Nasdaq
- Market Cap
- TRVI 383.4M
- AIP 433.5M
- IPO Year
- TRVI 2019
- AIP 2021
- Fundamental
- Price
- TRVI $6.50
- AIP $7.09
- Analyst Decision
- TRVI Strong Buy
- AIP Strong Buy
- Analyst Count
- TRVI 8
- AIP 4
- Target Price
- TRVI $17.56
- AIP $12.75
- AVG Volume (30 Days)
- TRVI 4.4M
- AIP 160.6K
- Earning Date
- TRVI 03-18-2025
- AIP 05-01-2025
- Dividend Yield
- TRVI N/A
- AIP N/A
- EPS Growth
- TRVI N/A
- AIP N/A
- EPS
- TRVI N/A
- AIP N/A
- Revenue
- TRVI N/A
- AIP $57,724,000.00
- Revenue This Year
- TRVI N/A
- AIP $19.68
- Revenue Next Year
- TRVI N/A
- AIP $18.13
- P/E Ratio
- TRVI N/A
- AIP N/A
- Revenue Growth
- TRVI N/A
- AIP 7.56
- 52 Week Low
- TRVI $2.30
- AIP $5.76
- 52 Week High
- TRVI $7.39
- AIP $12.64
- Technical
- Relative Strength Index (RSI)
- TRVI 66.37
- AIP 30.97
- Support Level
- TRVI $6.22
- AIP $7.67
- Resistance Level
- TRVI $6.79
- AIP $8.18
- Average True Range (ATR)
- TRVI 0.40
- AIP 0.29
- MACD
- TRVI -0.03
- AIP 0.04
- Stochastic Oscillator
- TRVI 52.24
- AIP 0.00
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.